Leukemia inhibitory factor (LIF) inhibits basal bone resorption in fetal rat long bone cultures

Cytokine ◽  
1990 ◽  
Vol 2 (4) ◽  
pp. 266-271 ◽  
Author(s):  
Joseph A. Lorenzo ◽  
Sandra L. Sousa ◽  
Christina L. Leahy
1990 ◽  
Vol 10 (3) ◽  
pp. S267-S268
Author(s):  
Joseph Lorenzo ◽  
Christina Leahy ◽  
Sandra Sousa

Cytokine ◽  
1994 ◽  
Vol 6 (4) ◽  
pp. 368-375 ◽  
Author(s):  
Donald R. Bertolini ◽  
Bartholomew Votta ◽  
Sandra Hoffman ◽  
Gideon Strassmann

1999 ◽  
Vol 276 (3) ◽  
pp. E465-E471
Author(s):  
Samuel Varghese ◽  
Kyung Yu ◽  
Ernesto Canalis

Leukemia inhibitory factor (LIF) and oncostatin M (OSM) have multiple effects on skeletal remodeling. Although these cytokines modestly regulate collagen synthesis in osteoblasts, their effects on collagenase expression and collagen degradation are not known. We tested whether LIF and OSM regulate the expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in osteoblast-enriched cells isolated from fetal rat calvariae. LIF and OSM increased collagenase-3 (MMP-13) mRNA and immunoreactive protein levels in a time- and dose-dependent manner. LIF and OSM enhanced the rate of transcription of the collagenase gene and stabilized collagenase mRNA in transcriptionally arrested cells. LIF and OSM failed to regulate the expression of gelatinase A (MMP-2) and B (MMP-9). LIF and OSM modestly stimulated the expression of TIMP-1 but did not alter the expression of TIMP-2 and -3. In conclusion, LIF and OSM stimulate collagenase-3 and TIMP-1 expression in osteoblasts, and these effects may be involved in mediating the bone remodeling actions of these cytokines.


Sign in / Sign up

Export Citation Format

Share Document